Ignite Creation Date:
2024-05-05 @ 11:43 PM
Last Modification Date:
2024-10-26 @ 10:38 AM
Study NCT ID:
NCT01392495
Status:
TERMINATED
Last Update Posted:
2015-08-10
First Post:
2011-07-11
Brief Title:
Extension to CQTI571A2102 to Evaluate Long-term Safety Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension PAH
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CQTI571A2102E1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None